An Analysis of Nectin-4 (<i>PVRL4</i>) in Penile Squamous Cell Carcinoma.

"appendix a supplementary data the following are the supplementary data to this article: supplementary data 1 appendix a supplementary data to this article can be found online at https://doi org/10 1016/j euros2022 12 008 ."

" Philippe E. Spiess certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg, employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: Jad Chahoud has received advisory board fees from Pfizer, Exelixis, and Aveo, none in relation to this work. Philippe E. Spiess has no financial disclosures to report and only leadership disclosures: President of Global Society of Rare Genitourinary Tumors, NCCN bladder and penile cancer vice-chair, Member of ASCO/EAU penile cancer panel. The other authors have no relevant disclosures related to this work."

"Financial disclosures: Philippe E. Spiess certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg, employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: Jad Chahoud has received advisory board fees from Pfizer, Exelixis, and Aveo, none in relation to this work. Philippe E. Spiess has no financial disclosures to report and only leadership disclosures: President of Global Society of Rare Genitourinary Tumors, NCCN bladder and penile cancer vice-chair, Member of ASCO/EAU penile cancer panel. The other authors have no relevant disclosures related to this work. Funding/Support and role of the sponsor:"